“Design And Synthesis Of 3-Arylcoumerin Derivatives As A Selective Mao-B Inhibitor” (2022) Journal of Pharmaceutical Negative Results, pp. 9820–9833. doi:10.47750/pnr.2022.13.S09.1147.